tbuckley/cabot-search huggingface dataset:
Are YOU getting naked?
Authors: Karen Hebert
Journal: BMJ (2008)

A sign adorning the door of an NHS clinical investigation unit reads, "Are you NAKED below the elbows? Do not enter if you are not." This is one of the most obvious results of the Department of Health's Bare Below the Elbows campaign. <b>Karen Hebert</b> investigates nakedness, loss of watches, and the impact on professional appearance
An OSCE actress
Authors: Sabreena Malik
Journal: BMJ (2006)

Heather Batten is a senior research executive with Condé Nast Publications and a drama student at the Poor School in London. In the November obstetrics and gynaecology objective structured clinical examinations (OSCEs) she played the part of a 30 year old with an abnormal smear and a pregnant 25 year old whose membranes have ruptured at 22 weeks.
Childhood asthma clusters reveal neutrophil‐predominant phenotype with distinct gene expression
Authors: M.‐W. Su, W.‐C. Lin, C.‐H. Tsai, B.‐L. Chiang, Y.‐H. Yang, Y.‐T. Lin, L.‐C. Wang, J.‐H. Lee, C.‐C. Chou, Y.‐F. Wu, Y.‐L. Yeh, Y. L. Lee
Journal: Allergy (2018)

Childhood asthma comprises different phenotypes with complex pathophysiology. Different asthma phenotypes evoke various clinical symptoms and vary in their responses to treatments.We applied k-means clustering algorithm of twelve objective laboratory tests among 351 asthmatic children enrolled in the Taiwanese Consortium of Childhood Asthma Study (TCCAS). We constructed gene expression profiles of peripheral blood mononuclear cells (PBMC) from children with different asthma phenotypes.Five distinct phenotypes of childhood asthma were identified and can be characterized by either eosinophil-predominant or neutrophil-predominant inflammatory characteristics. In the gene expression profile analysis, significant differences were noted for neutrophil-predominant asthma, compared with samples from all the other asthma phenotypes. The vast majority of the differentially expressed genes in neutrophil-predominant asthma was associated with corticosteroid response. From an independent inhaled corticosteroid (ICS) response cohort, we also found neutrophils could be activated in this severe asthma phenotype and neutrophil-predominant asthma may be associated with corticosteroid nonresponsiveness.Phenotype clustering of childhood asthma can be helpful to identify clinically relevant patients and reveal different inflammatory characteristics in asthmatic children. Neutrophil-predominant asthma is the most severe asthma phenotype with poor corticosteroid response. Gene expression profile of different asthma phenotypes not only improve our knowledge of childhood asthma, but also can guide asthma precision medicine.
Infant Mortality Due to Unintentional Suffocation Among Infants Younger Than 1 Year in the United States, 1999-2015
Authors: Yuyan Gao, David C. Schwebel, Guoqing Hu
Journal: JAMA Pediatrics (2018)

Unintentional suffocation is largely preventable, but it caused 87% of deaths due to unintentional injury among children younger than 12 months in the United States in 2015. 1 During the past 2 decades, substantial public and private efforts have been devoted to preventing mortality from infant suffocation, especially through safer sleeping. 2,3Based on recently updated data, we examined mortality from unintentional suffocation from 1999 to 2015 in the United States among infants younger than 1 year.Methods | Mortality data were extracted from the Centers for Disease Control and Prevention online WONDER (Wideranging Online Data for Epidemiologic Research) database. 4Unintentional suffocation includes International Statistical
THE CHANGES IN GLOBAL CORONARY BLOOD FLOW AFTER PCI EVALUATED BY CARDIOVASCULAR MAGNETIC RESONANCE IMAGING AND THEIR RELATIONSHIP WITH PHYSIOLOGICAL INDICES OBTAINED BY A PRESSURE WIRE
Authors: Yoshihisa Kanaji, Taishi Yonetsu, Eisuke Usui, Masahiro Hoshino, Yohei Sumino, Hiroaki Ohya, Tadashi Fukuda, Rikuta Hamaya, Yoshinori Kanno, Tsunekazu Kakuta
Journal: Journal of the American College of Cardiology (2018)
MSc in clinical and public health aspects of addiction
Authors: Rahul Rao
Journal: BMJ (2006)

Further information 

Dr Kim Wolff (programme leader), National Addiction Centre, Addiction Sciences Building, Institute of Psychiatry (P048), 4 Windsor Walk, London SE5 8AF; +44 (0)207 848 0823; www.iop.kcl.ac.uk/iopweb/studying/taught.

For students with a medical, nursing, psychology, or psychiatry background who have an interest in the substance misuse field.

2003 to 2005, after six years as a consultant in old age psychiatry.

To improve the detection and treatment of alcohol and other drug misuse in older people in my own service, and to integrate research …
An overview of graphene-based hydroxyapatite composites for orthopedic applications
Authors: Ming Li, Pan Xiong, Feng Yan, Sijie Li, Changhong Ren, Zhichen Yin, Ang Li, Huafang Li, Xunming Ji, Yufeng Zheng, Yan Cheng
Journal: Bioactive Materials (2018)

Hydroxyapatite (HA) is an attractive bioceramic for hard tissue repair and regeneration due to its physicochemical similarities to natural apatite. However, its low fracture toughness, poor tensile strength and weak wear resistance become major obstacles for potential clinical applications. One promising method to tackle with these problems is exploiting graphene and its derivatives (graphene oxide and reduced graphene oxide) as nanoscale reinforcement fillers to fabricate graphene-based hydroxyapatite composites in the form of powders, coatings and scaffolds. The last few years witnessed increasing numbers of studies on the preparation, mechanical and biological evaluations of these novel materials. Herein, various preparation techniques, mechanical behaviors and toughen mechanism, the in vitro/in vivo biocompatible analysis, antibacterial properties of the graphene-based HA composites are presented in this review.
CARDIAC AND INFLAMMATORY BIOMARKERS IN PERINATALLY HIV-INFECTED AND HIV-EXPOSED UNINFECTED CHILDREN
Authors: James D. Wilkinson, Paige L. Williams, Wendy Yu, Steven Colan, Armando Mendez, Justin Zachariah, Russell B. Van Dyke, William T. Shearer, Renee Margossian, Steven Lipshultz
Journal: Journal of the American College of Cardiology (2018)
SEVERE FUNCTIONAL TRICUSPID VALVE REGURGITATION: PREDICTORS OF MORTALITY AND HEART FAILURE ADMISSION
Authors: Lin Fei Perryn Ng, Edgar Tay, Wern Miin Soo, Siew Pang Chan, Lieng Ling, Tiong Cheng Yeo, Raymond Wong, Kian Keong Poh, William K.F. Kong, Robin Cherian
Journal: Journal of the American College of Cardiology (2018)
Challenges in Understanding Differences in Health Care Spending Between the United States and Other High-Income Countries
Authors: Katherine Baicker, Amitabh Chandra
Journal: JAMA (2018)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
UTILIZATION OF MECHANICAL CIRCULATORY SUPPORT DEVICES IN CHORDAE TENDINAE AND PAPILLARY MUSCLE RUPTURE COMPLICATING ST-ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM NATIONWIDE INPATIENT SAMPLE
Authors: Mohit Pahuja, Manmohan Singh, Achint Patel, Kinsuk Chauhan, Tushar Mishra, Tomo Ando, Emmanuel Akintoye, Neha Debnath, Hossam Elhadi, Ahmad Yassin, Ahmad Subahi, Luis Afonso
Journal: Journal of the American College of Cardiology (2018)
CO-MORBIDITIES AND ETHNICITY/RACE PREDICT MORBIDITY AND MORTALITY IN HIGH RISK HEART FAILURE PATIENTS WITH SYSTOLIC DYSFUNCTION: THE GUIDE-IT PREDICTIVE RISK MODEL
Authors: Christopher M. O’Connor, Mona Fiuzat, Adrian Coles, Hillary Mulder, Kevin Anstrom, Tariq Ahmad, Kirkwood Adams, Ileana L. Pina, Lawton Cooper, Patrice Nickens, Daniel Mark, Justin Ezekowitz, James Januzzi, Eric Leifer, G. Michael Felker
Journal: Journal of the American College of Cardiology (2018)
Doctors taking parental leave can face effective demotion, researchers find
Authors: Tom Moberly
Journal: BMJ (2015)

Doctors taking maternity or paternity leave can find themselves effectively demoted when they return to work, a group of researchers in Germany has concluded.1

The researchers looked at experiences of healthcare staff working in competitive hospital environments. They found that 51% of staff experienced significant changes in their tasks and that 17% of senior staff lost status after returning from parental leave. Staff who returned from parental …
ARTERIAL STIFFNESS AND ENDOTHELIAL FUNCTION FOR THE RISK ASSESSMENT OF NEW DIABETIC RETINOPATHY DEVELOPMENT IN TYPE 2 DIABETES
Authors: Evangelos Oikonomou, Alexios Antonopoulos, Nikolaos Gouliopoulos, Gerasimos Siasos, Marilita Moschos, Theodosia Konsola, Christina Kollia, Georgia Siasou, Theodore Paraskevopoulos, Emmanouil Vavuranakis, Eva Kassi, Nikolaos Tentolouris, Charalambos Antoniades, Christodoulos Stefanadis, Dimitris Tousoulis
Journal: Journal of the American College of Cardiology (2018)
CLINICAL FEASIBILITY OF NON-OBSTRUCTIVE AORTIC ANGIOSCOPY FOR ASSESSING ATHEROSCLEROTIC PATHOLOGY OF HUMAN AORTIC VALVE IN VIVO: A NOVEL APPROACH
Authors: Keisuke Kojima, Tadateru Takayama, Takafumi Hiro, Suguru Migita, Morikawa Tomoyuki, Takehiro Tamaki, Takashi Mineki, Takaaki Kogo, Yoshiaki Yamane, Naotaka Akutsu, Nobuhiro Murata, Toru Oshima, Mitsumasa Sudo, Daisuke Kitano, Daisuke Fukamachi, Hironori Haruta, Atsushi Hirayama
Journal: Journal of the American College of Cardiology (2018)
Contract imposition will be Pyrrhic victory for government, says Royal College of Surgeons
Authors: Abi Rimmer
Journal: BMJ (2016)

Imposing a contract on junior doctors in England will be a Pyrrhic victory for the government, given the damage the plans have done to morale, the Royal College of Surgeons of England has said.

In an open letter to its trainee members, sent on Friday 16 September, the college’s council and its president, Clare Marx, said that it was unclear what the proposed new contract for junior doctors aimed to achieve.

“Although patients could benefit …
Questions About Emergency Department Treatment of Patients With Solid Tumors and Hematological Malignant Neoplasms—Reply
Authors: Donna R. Rivera, Jeremy Brown, Nonniekaye Shelburne
Journal: JAMA Oncology (2018)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Two-year follow-up from the phase 3 KEYNOTE-045 trial of pembrolizumab (pembro) vs investigator’s choice (paclitaxel, docetaxel, or vinflunine) in recurrent, advanced urothelial cancer (UC).
Authors: Joaquim Bellmunt, Ronald De Wit, David J. Vaughn, Yves Fradet, Jae-Lyun Lee, Lawrence Fong, Nicholas J. Vogelzang, Miguel A. Climent, Daniel Peter Petrylak, Toni K. Choueiri, Andrea Necchi, Winald Gerritsen, Howard Gurney, David I. Quinn, Stephane Culine, Cora N. Sternberg, Kijoeng Nam, Tara L. Frenkl, Rodolfo F. Perini, Dean F. Bajorin
Journal: Journal of Clinical Oncology (2018)

410 Background: Based on interim results from the phase 3 KEYNOTE-045 (NCT02256436) study comparing pembro v investigator’s choice of chemotherapy (chemo), pembro was approved for the treatment of locally advanced or metastatic UC that has progressed during or after a platinum-containing regimen. Updated results after 2 years of follow-up are presented. Methods: Eligible patients (histologically or cytologically confirmed UC, progression after platinum, ECOG PS 0-2, measurable disease per RECIST v1.1, ≤2 lines of systemic therapy) were randomly assigned 1:1 to pembro 200 mg Q3W or investigator’s choice of paclitaxel 175 mg/m 2 Q3W, docetaxel 75 mg/m 2 Q3W, or vinflunine 320 mg/m 2 Q3W. Primary efficacy end points were OS and PFS (RECIST v1.1, blinded central review). ORR (RECIST v1.1, blinded central review) was a secondary end point. Results: As of Oct 26, 2017, among the 542 enrolled patients (pembro, 270; chemo, 272), median follow-up was 27.7 mo. Median OS was significantly longer with pembro v chemo (10.3 v 7.3 mo; HR, 0.70; P &lt; 0.0002). OS benefit with pembro v chemo was seen in all PD-L1 expression subgroups (HR: combined positive score [CPS] &lt; 1, 0.82; CPS ≥1, 0.58; CPS &lt; 10, 0.75; CPS ≥10, 0.56) and was maintained regardless of age, ECOG PS, prior therapy, liver metastases, baseline hemoglobin, time from last chemo, histology, risk factor group, and choice of chemo. PFS was not different between arms (2.1 v 3.3 mo; HR, 0.96; P = 0.32). ORR was higher with pembro v chemo (21.1% v 11.0%). Median duration of response was longer with pembro (not reached [1.6+–30.3+ mo] v 4.4 mo [1.4+–29.9+ mo]), and a greater proportion of responses lasted ≥12 mo (68% v 35%) as assessed by Kaplan-Meier method. Fewer patients with pembro v chemo experienced a treatment-related adverse event of any grade (62.0% v 90.6%) and a grade ≥3 adverse event (16.5% v 50.2%). Conclusions: Results observed over 2 years of follow-up, including OS benefit and superior safety with pembro v chemo, were consistent with the interim analyses that led to the approval of pembro in locally advanced or metastatic UC that progressed during or after platinum-based chemotherapy. Clinical trial information: NCT02256436.
Consultant cover on maternity wards has risen
Authors: Matthew Limb
Journal: BMJ (2013)

Consultant cover on UK maternity wards has increased, including at weekends, latest figures show.

The Royal College of Obstetricians and Gynaecologists said that medical workforce census data, published on 20 September, showed that the specialty was “moving in the right direction.”

Census data for 203 units were provided for 2012-13 by college tutors who coordinate training and education within …
Younger generation of doctors increasingly likely to stay local
Authors: Caroline White
Journal: BMJ (2013)

Current doctors are more likely to train and work near where they grew up than previous generations were, indicates research published in the Journal of the Royal Society of Medicine .1

The authors assessed the geographical mobility of more than 31 000 doctors who qualified in the UK between 1974 and 2008, though cohorts that qualified after 2000 were excluded from some …
Phenotipic analysis of neutrophil population from GBM patients
Authors: Patricia Coelho, Alison Harris, Fiona Murphy, Tracie Plant, Shonna Johnston, Imran Liaquat, Paul Brennan, Moira Whyte, Sarah Walmsley
Journal: Neuro-Oncology (2018)

Gliobalstomas (GBM) are the most prevalent type of malignant brain tumour with the median survival from diagnosis in the region of 6–9 months. GBM are both highly infiltrated with neutrophils and demonstrate a high degree of regional hypoxia. Recently, the description of neutrophil gene signatures as prognostic markers in human cancers has raised important questions as to the role neutrophil subsets may play in defining cancer outcomes. Extending from the observations that neutrophils are diverse cells with an array of functions and plasticity more recent work has identified the presence of low-density neutrophil populations within the circulation of a heterogeneous group of patients with breast and lung malignancy, and also in mice with mammary tumour. In vitro they exhibit reduced chemotactic and phagocytic responses and have been named granulocytic-myeloid-derived suppressor cells (g-MDSCs). This project aimed to characterise blood and tumour derived neutrophil populations in glioblastoma patients using flow based phenotypic analysis (CD45, CD66b, CD49d, CD15, CD16b). A sub population of CD45+/CD66b+/CD49d-/CD15+/high neutrophils was identified. These neutrophils fall within the low-density neutrophil population, and can be further separated into CD16b+ and CD16b- cells. Parallel analysis of neutrophils isolated from the GBM tumour tissue of these patients has identified an augmented CD45, CD66b and CD15 expression profile compared to the blood neutrophil population, as determined by mean fluorescence intensities. These low density CD66bhigh/CD15+/high/CD16b- populations matched the expression profiles ascribed to g-MDSCs (Lineage-, HLA-DR-, CD33+, CD14-, CD15+, CD66b+), the origin of which is currently the source of ongoing research within the field and an area of some debate. Whilst it is clear these cells do not simply represent a de-granulated state, experimental evidence supporting their production in the marrow in response to a malignant state is currently lacking. Similarly the mechanisms driving the proposed immune suppressive function of these cells are largely unknown.
Advanced course in genomics and clinical microbiology
Authors: Vanessa Wong, Fiona Cooke
Journal: BMJ (2011)

This one week course run by the Wellcome Trust is designed to provide practical laboratory based training in the application of current genetic techniques to the general microbiology laboratory, with a specific focus on bacteriology.

The course is designed for anyone interested in the infection specialties—in particular specialist registrars and consultants in medical microbiology or infectious diseases; research workers; and clinical scientists. On our course there were 14 participants from a wide range of backgrounds, which included five international attendees.

It has been running since 2005 and is held each January at the Wellcome Trust Genome Campus, Hinxton, Cambridge.

The future of microbiology will be molecular. Certain aspects of clinical microbiology, such as screening for meticillin resistant …
Three-month post-treatment PSA as a biomarker of treatment response in intermediate or high-risk prostate cancer treated with androgen deprivation therapy and radiotherapy.
Authors: Bryant Alex, Anthony Victor D'Amico, Paul Nguyen, John Paul Einck, Christopher J. Kane, Rana R. McKay, Daniel Robert Simpson, Arno James Mundt, James Don Murphy, Brent Shane Rose
Journal: Journal of Clinical Oncology (2018)

99 Background: Prostate-specific antigen (PSA) measurement after definitive radiation therapy (RT) and androgen deprivation therapy (ADT) for localized prostate cancer (PC) has been proposed as an early prognostic biomarker. We investigate the association between 3-month post-RT PSA and biochemical progression-free survival (bPFS), prostate cancer-specific survival (PCSS), and overall survival (OS). Methods: We identified 5,783 patients with intermediate- or high-risk localized PC diagnosed between 2000-2015 and treated with RT and ADT from Veterans Affairs data. Patients were divided into groups based on 3-month post-RT PSA values: &lt; 0.10 ng/mL, 0.10-0.49 ng/mL, and ≥0.50 ng/mL. The effect of 3-month PSA group on bPFS, PCSS, and OS were evaluated in multivariable Cox models adjusting for potential confounders. Results: There were 2,651 intermediate risk and 3,132 high risk patients; 11% had a 3-month PSA of ≥0.50 ng/mL. Higher 3-month PSA was strongly associated with each outcome; compared to the &lt; 0.10 ng/mL group, we noted greater hazards for the 0.10-0.49 ng/mL group (HR for bPFS: 2.41, p &lt; 0.001; PCSS: 2.29, p &lt; 0.001; OS: 1.21, p = 0.003) and the ≥ 0.50 ng/mL group (HR for bPFS: 5.23; PCSS: 3.97; OS: 1.50; p &lt; 0.001 for all). When analyzed separately, 3-month PSA group was predictive of OS in the high-risk group (p &lt; 0.001) but not the intermediate-risk group (p = 0.21). Conclusions: 3-month post-RT PSA is a strong prognostic biomarker for bPFS and PCSS in patients with intermediate and high-risk PC, and OS in patients with high-risk PC. 3-month PSA measurement may augment clinical decision-making and holds promise as a potential surrogate endpoint in clinical trials.
O021 Mesenchymal stem cell-derived extracellular vesicles: a novel therapeutic option in systemic sclerosis
Authors: P Rozier, M Maumus, A Maria, K Toupet, C Jorgensen, P Guilpain, D Noel
Journal: Annals of the Rheumatic Diseases (2018)

<h3>Introduction</h3> Systemic sclerosis (SSc) is a rare intractable autoimmune disease, with unmet medical need. Cell therapy using mesenchymal stem cells (MSC) is a promising approach, and we recently reported its efficacy in a murine model of SSc induced by hypochlorite (HOCl). Since MSC act primarily through the secretion of soluble factors released within extracellular vesicles (EV), the use of EV instead of cells seems an attractive alternative. Herein, we compared the effects of two types of EV, exosomes and microparticles, in HOCl-induced SSc. <h3>Objectives</h3> Herein, we compared the effects of two types of EV, exosomes and microparticles, in HOCl-induced SSc. <h3>Methods</h3> BALB/c mice were challenged with daily intradermal HOCl injections during 6 weeks to induce SSc. Each group was treated at mid-experiment with infusions of 2.5×10<sup>5</sup> murine MSC, 250 ng of exosomes or microparticles isolated from IFNγ-activated or non-activated (NA) MSC. We measured skin thickness every week. At euthanasia (d42), we analysed the expression of fibrotic and inflammatory markers (collagens 1 and 3, αSma, TGFβ, MMP 1 and 9, TIMP1, IL1β, IL6, TNFα) in lungs and skin samples using RT-qPCR. <h3>Results</h3> Mice treated with each subtype of EV displayed lower clinical scores, less histological lesions, lower expression of fibrotic and inflammatory markers, with enhanced expression of remodelling parameters in skin and lung tissues. The observed effects were similar to those obtained with MSC. No difference was noted between NA and IFNγ-activated EV. <h3>Conclusions</h3> MSC-derived EV display potent antifibrotic properties in murine SSc. This new acellular therapy represents a promising approach in this disease. <h3>Disclosure of interest</h3> None declared
RISK OF LEAD DISLODGEMENT WITH CATHETER ABLATION IN PATIENTS WITH RECENTLY IMPLANTED CARDIAC IMPLANTABLE ELECTRONIC DEVICE: A FIVE-YEAR EXPERIENCE
Authors: Mohammad-Ali Jazayeri, Kevin Cokingtin, Brendan Cokingtin, Venkat Lakshmi Kishan Vuddanda, Courtney Jeffery, Valay Parikh, Donita Atkins, Sudharani Bommana, Loren Berenbom, Rhaguveer Dendi, Martin Emert, Dhanunjaya Lakkireddy, Rhea Pimentel, Madhu Reddy, Seth Sheldon
Journal: Journal of the American College of Cardiology (2018)